CRSP vs. INPST.AS

Last updated Jun 13, 2026

CRSP (CRISPR Therapeutics AG) and INPST.AS (Inpost SA) are both stocks. CRSP operates in Biotechnology (Healthcare), while INPST.AS operates in Specialty Business Services (Industrials). Over the past 5 years, CRSP returned -17.08%/yr vs -1.11%/yr for INPST.AS. At a 0.19 correlation, their price movements are largely independent.

Performance

CRSP vs. INPST.AS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CRISPR Therapeutics AG (CRSP) and Inpost SA (INPST.AS). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CRSP is traded in USD, while INPST.AS is traded in EUR. To make them comparable, the INPST.AS values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CRSP achieves a -5.03% return, which is significantly lower than INPST.AS's 44.09% return.

CRSP

• 1D: -0.86%
• 1M: 2.87%
• YTD: -5.03%
• 6M: -12.14%
• 1Y: 20.41%
• 3Y*: -6.43%
• 5Y*: -17.08%
• 10Y*: —

INPST.AS

• 1D: 0.09%
• 1M: 0.15%
• YTD: 44.09%
• 6M: 48.12%
• 1Y: 9.81%
• 3Y*: 20.05%
• 5Y*: -1.11%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRSP vs. INPST.AS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CRSP CRISPR Therapeutics AG	-5.03%	33.23%	-37.12%	54.00%	-46.36%	-55.30%
INPST.AS Inpost SA	44.09%	-28.07%	23.71%	63.95%	-30.13%	-47.56%

Correlation

The correlation between CRSP and INPST.AS is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jan 27, 2021	0.19

Return for Risk

CRSP vs. INPST.AS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRSP

CRSP Risk / Return Rank: 54
CRSP Sharpe Ratio Rank: 55
CRSP Sortino Ratio Rank: 55
CRSP Omega Ratio Rank: 52
CRSP Calmar Ratio Rank: 54
CRSP Martin Ratio Rank: 53

INPST.AS

INPST.AS Risk / Return Rank: 48
INPST.AS Sharpe Ratio Rank: 48
INPST.AS Sortino Ratio Rank: 48
INPST.AS Omega Ratio Rank: 50
INPST.AS Calmar Ratio Rank: 47
INPST.AS Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRSP vs. INPST.AS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CRISPR Therapeutics AG (CRSP) and Inpost SA (INPST.AS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRSP	INPST.AS	Difference
Sharpe ratio: Return per unit of total volatility	0.33	0.15	+0.19
Sortino ratio: Return per unit of downside risk	0.94	0.66	+0.28
Omega ratio: Gain probability vs. loss probability	1.11	1.09	+0.02
Calmar ratio: Return relative to maximum drawdown	0.49	0.18	+0.31
Martin ratio: Return relative to average drawdown	0.81	0.39	+0.42

CRSP vs. INPST.AS - Sharpe Ratio Comparison

The current CRSP Sharpe Ratio is 0.33, which is higher than the INPST.AS Sharpe Ratio of 0.15. The chart below compares the historical Sharpe Ratios of CRSP and INPST.AS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CRSP vs. INPST.AS - Drawdown Comparison

The maximum CRSP drawdown since its inception was -85.11%, roughly equal to the maximum INPST.AS drawdown of -82.02%. Use the drawdown chart below to compare losses from any high point for CRSP and INPST.AS.

Drawdown Indicators

	CRSP	INPST.AS	Difference
Max Drawdown Largest peak-to-trough decline	-85.11%	-82.02%	-3.09%
Max Drawdown (1Y) Largest decline over 1 year	-42.25%	-35.59%	-6.66%
Max Drawdown (3Y) Largest decline over 3 years	-64.91%	-47.09%	-17.82%
Max Drawdown (5Y) Largest decline over 5 years	-80.68%	-78.44%	-2.24%
Current Drawdown Current decline from peak	-76.29%	-29.80%	-46.49%
Average Drawdown Average peak-to-trough decline	-49.24%	-45.84%	-3.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.51%	16.92%	+8.59%

Volatility

CRSP vs. INPST.AS - Volatility Comparison

CRISPR Therapeutics AG (CRSP) has a higher volatility of 18.22% compared to Inpost SA (INPST.AS) at 1.49%. This indicates that CRSP's price experiences larger fluctuations and is considered to be riskier than INPST.AS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRSP	INPST.AS	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.22%	1.49%	+16.73%
Volatility (6M) Calculated over the trailing 6-month period	43.62%	32.31%	+11.31%
Volatility (1Y) Calculated over the trailing 1-year period	62.44%	45.05%	+17.39%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	60.65%	47.69%	+12.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	64.35%	47.91%	+16.44%

Dividends

CRSP vs. INPST.AS - Dividend Comparison

Neither CRSP nor INPST.AS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CRSP and INPST.AS in my portfolio?

CRSP and INPST.AS have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.